The hypothesis that human RIPK7 plays an important role in the innate immune inflammatory pathways is further strengthened by findings that RIPK7 polymorphisms enhance the risk of developing PD and inflammatory bowel disease [38,39,40,41]. Here, LRRK2 is linked to inflammatory bowel disease.